Products Affected - Description
Tygacil lyophilized powder for solution for injection, Pfizer
50 mg, 5 mL vial, 10 count (NDC 00008-4990-02)
50 mg, 10 mL vial, 10 count (NDC 00008-4990-20)
Reason for the Shortage
Pfizer has Tygacil on shortage due to manufacturing delays. The company is supplying 50 mg/5 mL vials during the shortage of the 10 mL vials.
Insufficient supplies for usual ordering.
Estimated Resupply Dates
Pfizer has Tygacil 50 mg/10 mL vials on back order and the company estimates a release date of 1st quarter 2017. Tygacil 50 mg/5 mL vials are on allocation.
September 7, June 9, May 27 and 2, February 3, January 12, 2016; December 9, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins